Sparebank 1 SMN
In an election meeting held on Wednesday 10th of February, the following were elected as the Equity Capital Certificates holders' representatives in SpareBank 1 SMN's supervisory board.
As members:
| 1 | Lars Bjarne Tvete, Trondheim – re-election | Re-elacted for 4 years |
| 2 | Åsmund Skår, Nesbru - re-election | Re-elacted for 4 years |
| 3 | Nils Martin Williksen, Rørvik - re-election | Re-elacted for 4 years |
| 4 | Nina Kleven, Trondheim - re-election | Re-elacted for 4 years |
| 5 | Olav Sem Austmo, Trondheim – new member | New member for 4 years |
| 6 | Ingrid Finboe Svendsen, Trondheim – new member | New member for 4 years |
| 7 | Helge Moen, Stjørdal – new member | New member for 4 years |
| 8 | Frode Hassel, Trondheim, new member – former alternate varamedlem | New member for 4 years |
As alternates:
| 1 | Jan Gunnar Heglund, Trondheim | Re-elacted for 4 years |
| 2 | Heidi Blengsli Aabel, Jakobsli | Re-elacted for 4 years |
| 3 | Sivert Dombu, Meldal | Re-elacted for 4 years |
| 4 | Frode Størdal, Trondheim | Re-elacted for 4 years |
| 5 | May Britt M. Bjørnevaag, Buvika | New member for 4 years |
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ALK Abello19.12.2025 22:46:46 CET | Press release
Major shareholder announcement
ALK Abello19.12.2025 22:46:46 CET | Pressemeddelelse
Storaktionærmeddelelse
Zealand Pharma19.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Boehringer Ingelheim Limited19.12.2025 21:10:00 CET | Press release
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Novartis Pharma AG19.12.2025 20:30:06 CET | Press release
Novartis and US government reach agreement on lowering drug prices in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
